GlassScriptPhysician profile
Aaron David Benson
NPI 1831398668
$3,615.26
in general payments reported to CMS, 2019-2025
32 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.78 · 2020: $490 · 2021: $833 · 2022: $856 · 2023: $431 · 2024: $353 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335 · Education: $10.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.54 |
| Education | $10.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $555.69 | 2020-2023 | Veozah |
| Abbvie INC. | $476.13 | 2020-2025 | Botox, Lupron Depot |
| Coloplast Corp | $399.18 | 2020-2025 | Speedicath, Porges Coloplast |
| Boston Scientific Corporation | $299.78 | 2019-2025 | Ams 700, Axonics, Watchman Flx |
| Antares Pharma, INC. | $219.63 | 2020-2022 | |
| Travere Therapeutics, INC. | $173.67 | 2020-2025 | Thiola |
| Procept Biorobotics Corporation | $167.10 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Pfizer INC. | $158.41 | 2020-2022 | |
| Histosonics, INC. | $142.83 | 2025 | |
| Teleflex LLC | $140.06 | 2021-2023 | Urolift |
| Sumitomo Pharma America, INC. | $111.71 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $101.67 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $74.48 | 2022-2025 | |
| Neotract INC. | $73.63 | 2020 | |
| Urovant Sciences INC | $62.97 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $60.91 | 2020-2021 | |
| Calyxo, INC. | $45.00 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $43.73 | 2022-2024 | Interstim |
| Ferring Pharmaceuticals INC. | $42.37 | 2025 | Adstiladrin |
| Myovant Sciences INC. | $31.47 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $30.39 | 2021 | |
| Laborie Medical Technologies Corp. | $29.74 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $29.73 | 2021-2022 | |
| Allergan, INC. | $24.47 | 2021-2022 | |
| Blue Earth Diagnostics | $18.64 | 2024 | |
| Conmed Corporation | $17.82 | 2024 | Airseal |
| Janssen Biotech, INC. | $17.38 | 2025 | Tremfya |
| Cycle Pharmaceuticals INC | $16.27 | 2025 | Venxxiva |
| Clarus Therapeutics INC. | $15.57 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $12.44 | 2021 | |
| Cook Medical LLC | $11.20 | 2020 | |
| Convatec INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.